APA (7th ed.) Citation

Ndong Akomezoghe, L., M'Bondoukwé, N. P., Mawili Mboumba, D. P., Ndong Ngomo, J. M., Moutombi Ditombi, B. C., Mihindou, C. J., . . . Bouyou Akotet, M. K. (2025). Efficacy and safety of albendazole 400 mg for 30 days compared to single dose of ivermectin in adult patients with low Loa loa microfilaremia: A non-inferiority randomized controlled trial. PLoS Neglected Tropical Diseases, 19(6), 1. https://doi.org/10.1371/journal.pntd.0012383

Chicago Style (17th ed.) Citation

Ndong Akomezoghe, Luccheri, Noé Patrick M'Bondoukwé, Denise Patricia Mawili Mboumba, Jacques Mari Ndong Ngomo, Bridy Chesly Moutombi Ditombi, Coella Joyce Mihindou, Roger Hadry Sibi Matotou, Valentin Migueba, and Marielle Karine Bouyou Akotet. "Efficacy and Safety of Albendazole 400 mg for 30 Days Compared to Single Dose of Ivermectin in Adult Patients with Low Loa Loa Microfilaremia: A Non-inferiority Randomized Controlled Trial." PLoS Neglected Tropical Diseases 19, no. 6 (2025): 1. https://doi.org/10.1371/journal.pntd.0012383.

MLA (9th ed.) Citation

Ndong Akomezoghe, Luccheri, et al. "Efficacy and Safety of Albendazole 400 mg for 30 Days Compared to Single Dose of Ivermectin in Adult Patients with Low Loa Loa Microfilaremia: A Non-inferiority Randomized Controlled Trial." PLoS Neglected Tropical Diseases, vol. 19, no. 6, 2025, p. 1, https://doi.org/10.1371/journal.pntd.0012383.